24/7 Patient Assistance: 760-405-8205
24/7 Patient Assistance: 760-405-8205
Hospitals & Clinics
specialties & services
Dr. Joseph Merriman is a specialist in oncology, located in Nashville, Tennessee and works with Vanderbilt University Medical Center. He got his diploma from University of Tennessee College of Medicine and did his residency in Internal Medicine at the University of Utah. He completed his fellowship in Hematology/Oncology at Vanderbilt University and has almost 5 years of practice.
University of Utah
Residency
Vanderbilt University
Fellowship
University of Tennessee College of Medicine
Medical School
The University of the South Other Training , Biology, Economics
Sewanee
Vanderbilt University Medical Center
Languages: English/Spanish
(615) 322-5000
1211 Medical Center Dr
Nashville, Tennessee 37232 
Conditional survival of metastatic renal cell carcinoma patients treated with high-dose interleukin-2.
Gill DM, Stenehjem DD, Parikh K, Merriman J, Sendilnathan A, Agarwal AM, Hahn AW, Gupta S, Tantravahi SK, Samlowski WE, Agarwal N; Ecancermedicalscience. 2016.
See more >>
Paraneoplastic opsoclonus associated with squamous cell carcinoma of the tongue.
Wynn D, Merriman J, Patel AB, Hitchcock YJ, Garrido-Laguna I, Renner D, Clardy SL; Clin Neurol Neurosurg. 2016 Oct.
See more >>
Extension of overall survival beyond objective responses in patients with metastatic renal cell carcinoma treated with high-dose interleukin-2.
Stenehjem DD, Toole M, Merriman J, Parikh K, Daignault S, Scarlett S, Esper P, Skinner K, Udager A, Tantravahi SK, Gill D, Straubhar AM, Agarwal AM, Grossmann KF, Saml...; Cancer Immunol Immunother. 2016 Aug.
See more >>
Durable Response to Treatment With Combination Radiotherapy and High-dose Interleukin-2 in Metastatic Chromophobe Variant Renal Cell Carcinoma.
Merriman J, Tward J, Albertson D, Dechet C, Agarwal N; J Immunother. 2016 Feb-Mar.
See more >>Memberships
American Society of Clinical Oncology
